Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience

BackgroundCinacalcet is a calcimimetic approved in adults with primary hyperparathyroidism (PHPT). Few cases reports described its use in pediatric HPT, with challenges related to the risk of hypocalcemia, increased QT interval and drug interactions. In this study, we report the French experience in...

Full description

Bibliographic Details
Main Authors: Julie Bernardor, Sacha Flammier, Jean-Pierre Salles, Cyril Amouroux, Mireille Castanet, Anne Lienhardt, Laetitia Martinerie, Ivan Damgov, Agnès Linglart, Justine Bacchetta
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pediatrics
Subjects:
children
primary hyperparathyroidism
cinacalcet
hypercalcemia
Calcium-sensing Receptor (CaSR)
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.926986/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.926986/full

Similar Items